z-logo
open-access-imgOpen Access
<p>Expression of PD-1 and PD-L1 on Tumor-Infiltrating Lymphocytes Predicts Prognosis in Patients with Small-Cell Lung Cancer</p>
Author(s) -
Chengtao Sun,
Liping Zhang,
Wei Zhang,
Yü Liu,
Bin Chen,
Sha Zhao,
Wei Li,
Lei Wang,
Lingyun Ye,
Keyi Jia,
Hao Wang,
Chunyan Wu,
Yayi He,
Caicun Zhou
Publication year - 2020
Publication title -
oncotargets and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.054
H-Index - 60
ISSN - 1178-6930
DOI - 10.2147/ott.s252031
Subject(s) - tumor infiltrating lymphocytes , pd l1 , foxp3 , cd8 , immunohistochemistry , medicine , lung cancer , immune system , cd3 , tumor microenvironment , cancer research , oncology , immunology , immunotherapy
Immune therapy has shown good results in small-cell lung cancer (SCLC), but the impact of immune microenvironment of the disease is unclear. In this work, we detected expression of programmed death 1 (PD-1), PD-ligand 1 (PD-L1), and other immune biomarkers of cancer. We also analyzed the correlations between these markers and survival in SCLC.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here